To assess the efficacy and safety of 14-day bismuth/amoxicillin/PCAB triple therapy for the treatment of Helicobacter pylori infection in Taiwan
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
200
vonoprazan 20mg, Twice a day amoxicillin 750mg,Four times a day tripotassium dicitrate bismuthate 300mg,Four times a day for 14 days
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan
Eradicaton rate of Helicobacter pylori
13CUBT
Time frame: 6 weeks after finishing study drugs
evaluate side effect
evaluate drugy side effect by Questionnaire
Time frame: 2days after taking medicine
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.